Completion of dosing for 5,041 subjects in the Phase 2b NAVIGATE clinical trial, indicating significant progress in the development of CD388 for influenza prevention. Publication of preclinical data ...
COURSEDATE OF EXAMINATION DATE OF REVIEW Anthropology I June 12 June 11 Anthropology II June 6 June 5 Anthropology 3 June 3 June 2 Astronomy 1b June 5 June 4 Astronomy 2b June 6 June 5 Botany I June 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results